We are live on
!
Find out more
HI
Humankind Investments Portfolio holdings
AUM
$175M
1-Year Est. Return
14.3%
This Fund
S&P 500
This Quarter
Est. Return
+3.44%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
–
AUM
$223M
AUM Growth
-$214M
(-49%)
Cap. Flow
-$220M
Cap. Flow
% of AUM
-98.57%
Top 10 Holdings %
Top 10 Hldgs %
86.7%
Holding
153
New
–
Increased
3
Reduced
4
Closed
135
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$8.12M |
| 2 |
Sony
SONY
|
+$1.12M |
| 3 |
iShares ESG Advanced MSCI EAFE ETF
DMXF
|
+$6.79K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HKND
Humankind US Stock ETF
HKND
|
+$98.4M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$7.46M |
| 3 |
Apple
AAPL
|
+$5.83M |
| 4 |
Archer Daniels Midland
ADM
|
+$5.2M |
| 5 |
AbbVie
ABBV
|
+$3.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.74% |
| 2 | Consumer Discretionary | 0% |
| 3 | Consumer Staples | 0% |
| 4 | Financials | 0% |
| 5 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Prudential Financial
PRU
$41.8B
| – | – |
-2,464
| Closed | -$256K |
|
127
Qualcomm
QCOM
$176B
| – | – |
-1,820
| Closed | -$303K |
|
128
QuidelOrtho
QDEL
$838M
| – | – |
-8,206
| Closed | -$242K |
|
129
Regeneron Pharmaceuticals
REGN
$80.8B
| – | – |
-1,275
| Closed | -$717K |
|
130
ResMed
RMD
$30.7B
| – | – |
-1,321
| Closed | -$362K |
|
131
Sunrun
RUN
$2.46B
| – | – |
-16,247
| Closed | -$281K |
|
|
SEM
132
DELISTED
Select Medical
SEM
| – | – |
-12,483
| Closed | -$160K |
|
133
J.M. Smucker
SJM
$12.8B
| – | – |
-4,927
| Closed | -$535K |
|
134
Stryker
SYK
$130B
| – | – |
-5,281
| Closed | -$1.95M |
|
135
AT&T
T
$163B
| – | – |
-44,526
| Closed | -$1.26M |
|
136
Teleflex
TFX
$5.98B
| – | – |
-2,827
| Closed | -$346K |
|
137
Target
TGT
$68B
| – | – |
-3,212
| Closed | -$288K |
|
138
Tenet Healthcare
THC
$21.1B
| – | – |
-2,137
| Closed | -$434K |
|
139
Thermo Fisher Scientific
TMO
$220B
| – | – |
-3,812
| Closed | -$1.85M |
|
140
T-Mobile US
TMUS
$190B
| – | – |
-2,358
| Closed | -$564K |
|
141
Tesla
TSLA
$1.3T
| – | – |
-534
| Closed | -$237K |
|
142
Universal Health Services
UHS
$10.5B
| – | – |
-1,403
| Closed | -$287K |
|
143
UnitedHealth
UNH
$370B
| – | – |
-4,215
| Closed | -$1.46M |
|
144
Visa
V
$677B
| – | – |
-670
| Closed | -$229K |
|
145
Veralto
VLTO
$24B
| – | – |
-2,434
| Closed | -$259K |
|
146
Vertex Pharmaceuticals
VRTX
$126B
| – | – |
-2,864
| Closed | -$1.12M |
|
147
Viatris
VTRS
$18.9B
| – | – |
-33,416
| Closed | -$331K |
|
148
Verizon
VZ
$196B
| – | – |
-31,655
| Closed | -$1.39M |
|
149
Wells Fargo
WFC
$264B
| – | – |
-7,509
| Closed | -$629K |
|
150
Walmart Inc
WMT
$890B
| – | – |
-4,543
| Closed | -$468K |
|
Similar funds
MWM
BCVI
CC
BW
DWA
APCM
RWA
BC
Humankind Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Humankind Investments held 153 positions worth $223M, down 49% from $437M the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Humankind Investments withdrew a net $220M in Q4 2025, closing 135 positions and reducing 4 holdings. Its most notable exit was Humankind US Stock ETF, an estimated $98.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
Against the trend, Humankind Investments added an estimated $8.12M to iShares Biotechnology ETF.
- Humankind Investments added most to iShares Biotechnology ETF in Q4 2025, an estimated $8.12M increase.
- Humankind Investments's biggest Q4 2025 reduction was Apple, cutting an estimated $5.83M.
- Humankind Investments fully exited Humankind US Stock ETF in Q4 2025, selling an estimated $98.4M.
- Humankind Investments's ten largest holdings make up 87% of its $223M portfolio in Q4 2025.
- Humankind Investments opened 0 new positions and closed 135 in Q4 2025.
- Humankind Investments's portfolio value fell 49% quarter-over-quarter to $223M.
Based on Humankind Investments's 13F filing for Q4 2025, filed 17 Feb 2026.